Peter R Galle Selected Research

Peter R Galle Research Topics

Disease

83	Neoplasms (Cancer) 10/2022 - 04/2003
57	Hepatocellular Carcinoma (Hepatoma) 10/2022 - 12/2005
27	Colorectal Neoplasms (Colorectal Cancer) 05/2021 - 01/2003
23	Fibrosis (Cirrhosis) 11/2022 - 01/2006
22	Infections 12/2021 - 04/2002
21	Inflammation (Inflammations) 10/2020 - 02/2003
19	Crohn Disease (Crohn's Disease) 01/2019 - 01/2002
18	Liver Cirrhosis (Hepatic Cirrhosis) 04/2022 - 09/2006
17	Liver Diseases (Liver Disease) 04/2022 - 01/2003
15	Liver Neoplasms (Liver Cancer) 09/2020 - 07/2006
14	Colitis 01/2019 - 01/2002
11	Neoplasm Metastasis (Metastasis) 06/2022 - 09/2003
10	Adenocarcinoma 06/2022 - 07/2006
10	Stomach Neoplasms (Stomach Cancer) 01/2019 - 09/2003
10	Ulcerative Colitis 07/2018 - 04/2003
9	Chronic Hepatitis C 11/2018 - 04/2002
9	Hepatitis C 10/2018 - 07/2007
9	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 07/2018 - 09/2004
8	Non-alcoholic Fatty Liver Disease 03/2022 - 04/2006
7	Colonic Neoplasms (Colon Cancer) 06/2014 - 04/2003
7	Carcinogenesis 06/2012 - 07/2005
7	Autoimmune Hepatitis 06/2010 - 03/2003
7	Hepatitis 07/2008 - 07/2004
6	Carcinoma (Carcinomatosis) 06/2022 - 01/2008
6	Hepatic Encephalopathy 01/2022 - 01/2019
6	Hemorrhage 01/2022 - 07/2004
6	Chronic Hepatitis B 08/2021 - 04/2002
6	COVID-19 04/2021 - 01/2020
6	Asthma (Bronchial Asthma) 06/2007 - 01/2002
5	Hypertension (High Blood Pressure) 01/2022 - 01/2013
5	Ascites 01/2022 - 05/2013
5	Liver Failure 01/2018 - 05/2004
5	Diarrhea 10/2017 - 01/2003
5	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 10/2013 - 08/2008
4	Cholangiocarcinoma 06/2022 - 07/2006
4	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022 - 06/2011
4	Disease Progression 01/2021 - 11/2002
4	Sepsis (Septicemia) 12/2020 - 07/2006
4	Reinfection 12/2018 - 01/2006
4	Esophageal Neoplasms (Esophageal Cancer) 09/2010 - 10/2006
4	Rheumatoid Arthritis 01/2009 - 03/2007
4	Respiratory Hypersensitivity 06/2007 - 12/2004
3	Acute Liver Failure (Fulminant Hepatic Failure) 05/2022 - 07/2004
3	End Stage Liver Disease 01/2022 - 05/2015

Drug/Important Bio-Agent (IBA)

21	Sorafenib (BAY 43-9006)FDA Link 04/2022 - 07/2008
20	Proteins (Proteins, Gene)FDA Link 01/2022 - 03/2005
20	CytokinesIBA 01/2018 - 01/2002
15	Antiviral Agents (Antivirals)IBA 08/2021 - 04/2002
14	Biomarkers (Surrogate Marker)IBA 10/2021 - 01/2009
14	Interleukin-6 (Interleukin 6)IBA 11/2019 - 01/2003
12	AntibodiesIBA 04/2021 - 10/2006
12	Messenger RNA (mRNA)IBA 01/2019 - 01/2002
10	Pharmaceutical PreparationsIBA 01/2022 - 01/2008
10	RamucirumabIBA 01/2022 - 01/2019
10	Biological ProductsIBA 12/2020 - 08/2006
9	alpha-Fetoproteins (alpha-Fetoprotein)IBA 01/2022 - 09/2013
9	Transcription Factors (Transcription Factor)IBA 12/2016 - 01/2002
8	Ribavirin (Virazole)FDA LinkGeneric 11/2018 - 04/2002
8	Chemokine ReceptorsIBA 07/2011 - 03/2005
8	Transforming Growth Factor beta (TGF-beta)IBA 07/2008 - 02/2003
7	EnzymesIBA 01/2022 - 03/2004
6	AutoantibodiesIBA 07/2021 - 11/2005
6	InterferonsIBA 11/2018 - 04/2002
6	LigandsIBA 03/2013 - 03/2005
6	Fluorouracil (Carac)FDA LinkGeneric 03/2013 - 01/2003
6	Irinotecan (Camptosar)FDA LinkGeneric 06/2012 - 01/2003
6	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2011 - 11/2002
5	atezolizumabIBA 10/2022 - 01/2020
5	AlbuminsIBA 09/2021 - 01/2015
5	Tyrosine Kinase InhibitorsIBA 01/2021 - 03/2008
5	Phosphotransferases (Kinase)IBA 06/2014 - 07/2007
5	ErbB Receptors (EGF Receptor)IBA 09/2012 - 07/2006
5	Azathioprine (Imuran)FDA LinkGeneric 04/2010 - 04/2003
4	Bevacizumab (Avastin)FDA Link 10/2022 - 01/2020
4	Transaminases (Aminotransferases)IBA 05/2022 - 03/2016
4	Insulin (Novolin)FDA Link 03/2022 - 04/2006
4	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2022 - 05/2015
4	Fetal Proteins (Fetoprotein)IBA 06/2021 - 01/2017
4	C-Reactive ProteinIBA 01/2021 - 11/2005
4	LipidsIBA 01/2021 - 06/2011
4	CarbohydratesIBA 07/2020 - 06/2011
4	Cetuximab (Erbitux)FDA Link 06/2017 - 07/2006
4	Chemokine CXCL12IBA 06/2016 - 03/2005
4	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2016 - 03/2008
4	Oxaliplatin (Eloxatin)FDA LinkGeneric 02/2013 - 01/2004
4	SteroidsIBA 01/2013 - 09/2006
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2011 - 08/2010
4	tyrosine receptor (receptor, tyrosine)IBA 09/2010 - 07/2007
4	Platelet-Derived Growth Factor alpha ReceptorIBA 03/2010 - 03/2008
4	OxazoloneIBA 09/2009 - 12/2002
4	Transforming Growth Factor beta1 (TGF beta 1)IBA 10/2008 - 03/2003
4	Leucovorin (Folinic Acid)FDA Link 07/2004 - 01/2003
3	Proton Pump InhibitorsIBA 01/2022 - 01/2020

Therapy/Procedure

81	Therapeutics 06/2022 - 01/2003
24	Liver Transplantation 01/2020 - 07/2004
13	Drug Therapy (Chemotherapy) 05/2021 - 01/2003
11	Lasers (Laser) 06/2018 - 09/2004
8	Immunotherapy 05/2021 - 04/2012
5	Ligation 04/2021 - 08/2006
4	Transplantation 01/2019 - 03/2004